These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 33522256)
1. Evaluation of a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal. McMahon C; Halfpap J; Zhao Q; Bienvenida A; Rose AE Ann Pharmacother; 2021 Oct; 55(10):1230-1235. PubMed ID: 33522256 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation. Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427 [TBL] [Abstract][Full Text] [Related]
3. Comparison of 3 Different Prothrombin Complex Concentrate Regimens for Emergent Warfarin Reversal: PCCWaR Study. Dietrich SK; Rowe S; Cocchio CA; Harmon AJ; Nerenberg SF; Blankenship PS Ann Pharmacother; 2021 Aug; 55(8):980-987. PubMed ID: 33305592 [TBL] [Abstract][Full Text] [Related]
4. Impact of timing and dosing of four-factor prothrombin complex concentrate administration on outcomes in warfarin-associated intracranial hemorrhage. Cicci CD; Weiss A; Dang C; Stanton M; Feldman R Pharmacotherapy; 2022 May; 42(5):366-374. PubMed ID: 35384000 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center. Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428 [TBL] [Abstract][Full Text] [Related]
6. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0. Zemrak WR; Smith KE; Rolfe SS; May T; Trowbridge RL; Hayes TL; Grindlinger GA; Seder DB Neurocrit Care; 2017 Dec; 27(3):334-340. PubMed ID: 28660341 [TBL] [Abstract][Full Text] [Related]
7. Four-factor prothrombin complex concentrate dose response relationship with INR for warfarin reversal. Yohe AS; Livings SE Am J Emerg Med; 2019 Aug; 37(8):1534-1538. PubMed ID: 31130370 [TBL] [Abstract][Full Text] [Related]
8. Prospective Evaluation of a Fixed-Dose 4-Factor Prothrombin Complex Concentrate Protocol for Urgent Vitamin K Antagonist Reversal. Bitonti MT; Rumbarger RL; Absher RK; Curran LM J Emerg Med; 2020 Feb; 58(2):324-329. PubMed ID: 31787372 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the safety and efficacy between 3-factor and 4-factor prothrombin complex concentrates for the reversal of warfarin. Kuroski JE; Young S Am J Emerg Med; 2017 Jun; 35(6):871-874. PubMed ID: 28161220 [TBL] [Abstract][Full Text] [Related]
10. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation. Sin JH; Berger K; Lesch CA J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767 [TBL] [Abstract][Full Text] [Related]
11. Initiation of a fixed-dose four-factor prothrombin complex concentrate protocol. Fuh L; Goldstein JN; Hayes BD J Thromb Thrombolysis; 2020 Jul; 50(1):217-220. PubMed ID: 31707622 [TBL] [Abstract][Full Text] [Related]
12. Emergent Warfarin Reversal With Fixed-Dose 4-Factor Prothrombin Complex Concentrate. Jansma B; Montgomery J; Dietrich S; Mixon MA; Peksa GD; Faine B Ann Pharmacother; 2020 Nov; 54(11):1090-1095. PubMed ID: 32418445 [TBL] [Abstract][Full Text] [Related]
14. Modified version of the American College of Cardiology's recommendation for low-dose prothrombin complex concentrate is effective for warfarin reversal. Gilbert BW; Morton L; Huffman JB; Roemer K; Potter A; Cassidy CD; Vasquez DG Am J Emerg Med; 2020 Apr; 38(4):806-809. PubMed ID: 31864879 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of fixed-dose versus variable-dose prothrombin complex concentrate for warfarin reversal. Bajdas H; Handzel M; Uttaro E; Jones CMC; Kokanovich K; Acquisto NM Thromb Res; 2022 Jun; 214():76-81. PubMed ID: 35512560 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of fixed versus variable-dose prothrombin complex concentrate for emergent reversal of vitamin K antagonists: A systematic review and meta-analysis. Condeni MS; Weant KA; Neyens RR; Eriksson EA; Miano TA Am J Emerg Med; 2024 Mar; 77():91-105. PubMed ID: 38118388 [TBL] [Abstract][Full Text] [Related]
18. Fixed dose 4-factor prothrombin complex concentrate for the emergent reversal of warfarin: a retrospective analysis. Astrup G; Sarangarm P; Burnett A J Thromb Thrombolysis; 2018 Feb; 45(2):300-305. PubMed ID: 29164374 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal in Patients with Intracranial Hemorrhage. Scott R; Kersten B; Basior J; Nadler M J Emerg Med; 2018 Jun; 54(6):861-866. PubMed ID: 29510892 [TBL] [Abstract][Full Text] [Related]
20. Adjusted versus actual body weight dosing of 4-factor prothrombin complex concentrate in obese patients with warfarin-associated major bleeding. Smetana KS; Ziemba R; May CC; Erdman MJ; Van Matre ET; Jones GM J Thromb Thrombolysis; 2019 Apr; 47(3):369-374. PubMed ID: 30460443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]